Suppr超能文献

根据血清促甲状腺激素的年龄特异性参考区间对老年糖尿病患者未诊断的甲状腺功能减退症进行筛查以及抗糖尿病药物的影响。

Screening of Undiagnosed Hypothyroidism in Elderly Persons with Diabetes according to Age-Specific Reference Intervals for Serum Thyroid Stimulating Hormone and the Impact of Antidiabetes Drugs.

作者信息

Fontes Rosita, Teixeira Patricia de Fatima Dos Santos, Vaisman Mario

机构信息

Hospital Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, 20241260 Rio de Janeiro, RJ, Brazil; Diagnosticos da America SA, Rio de Janeiro, RJ, Brazil.

Hospital Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, 20241260 Rio de Janeiro, RJ, Brazil.

出版信息

J Diabetes Res. 2016;2016:1417408. doi: 10.1155/2016/1417408. Epub 2016 Jun 15.

Abstract

Background. Studies have suggested that hypothyroidism is more frequent in the elderly with diabetes mellitus. However, an adaptation of TSH levels to age should be considered in this assessment. Some antidiabetes drugs reportedly interfere with TSH levels. The objectives of this study were to evaluate the prevalence of undiagnosed hypothyroidism in patients with diabetes and the influence of antidiabetes drugs. Material and Methods. 1160 subjects, 60 years and older (751 with diabetes), were studied; results were compared according to diabetes treatment and with persons without diabetes. TSH, FT4, antithyroperoxidase, fasting glucose, and HbA1c were measured. Results and Discussion. 6.4% of patients with diabetes had hypothyroidism, a higher prevalence compared with persons without diabetes (5.1%), but lower than observed in many studies. The use of age-specific TSH reference interval (RI) could explain this difference. Patients taking metformin (MTF) had TSH (showed in medians) slightly lower (2.8 mU/L) than those not on MTF (3.3 mU/L), p < 0.05. MTF doses influenced TSH levels. Conclusions. The use of specific TSH RI could avoid the misdiagnosis of hypothyroidism in elderly with diabetes. Patients in use of MTF as single drug had lower TSH than those using other medications and persons without diabetes.

摘要

背景。研究表明,甲状腺功能减退症在老年糖尿病患者中更为常见。然而,在评估时应考虑促甲状腺激素(TSH)水平随年龄的适应性变化。据报道,一些抗糖尿病药物会干扰TSH水平。本研究的目的是评估糖尿病患者中未诊断出的甲状腺功能减退症的患病率以及抗糖尿病药物的影响。材料与方法。对1160名60岁及以上的受试者(751名患有糖尿病)进行了研究;根据糖尿病治疗情况并与无糖尿病者进行了结果比较。测量了TSH、游离甲状腺素(FT4)、抗甲状腺过氧化物酶、空腹血糖和糖化血红蛋白(HbA1c)。结果与讨论。6.4%的糖尿病患者患有甲状腺功能减退症,其患病率高于无糖尿病者(5.1%),但低于许多研究中的观察结果。使用年龄特异性的TSH参考区间(RI)可以解释这种差异。服用二甲双胍(MTF)的患者TSH(中位数显示)略低于未服用MTF的患者(2.8 mU/L对3.3 mU/L),p<0.05。MTF剂量影响TSH水平。结论。使用特异性TSH RI可避免老年糖尿病患者甲状腺功能减退症的误诊。单独使用MTF的患者TSH低于使用其他药物的患者和无糖尿病者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5db/4925962/734683e234d4/JDR2016-1417408.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验